Equulus Therapeutics
PrivateCompany Overview
Equulus Therapeutics operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. It was founded in 2023.
Equulus Therapeutics is a biotechnology company developing non-hallucinogenic, psychedelic-inspired therapeutics for central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Equulus Therapeutics Comparables
Compare Equulus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delix Therapeutics | 85% | |
| DemeRx, Inc. | 83% | |
| Soneira Therapeutics | 81% |
For institutional investors. Book with your work email.
Equulus Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Equulus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Equulus Therapeutics's valuation, stock price, and market status.
Is Equulus Therapeutics a public or private company?
Equulus Therapeutics is a private company.
What is the current stock price of Equulus Therapeutics?
Equulus Therapeutics is a private company, so its shares have no public market price. Caplight tracks Equulus Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Equulus Therapeutics worth (valuation)?
Valuation information for Equulus Therapeutics is not publicly available.
Can I buy Equulus Therapeutics stock?
Equulus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Equulus Therapeutics's last funding round?
Funding round information for Equulus Therapeutics is not publicly available.
Who are the main investors in Equulus Therapeutics?
Investor information for Equulus Therapeutics is not publicly disclosed.
Will Equulus Therapeutics IPO soon?
No public IPO plans have been announced for Equulus Therapeutics.
How can I track Equulus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Equulus Therapeutics's shares on secondary markets.